TD Cowen Maintains Buy on Medtronic, Lowers Price Target to $100

Benzinga Newsdesk www.benzinga.com Negative 60.3%

Neg 60.3% Neu 0% Pos 0%

TD Cowen analyst Joshua Jennings maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $119 to $100.